Related Experiment Video
Updated: Jan 13, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Advanced Characterization of Environmental Pollutant Metabolism in Human Skin
Rafael Reis1, Martine Zanini2, Guillaume Lereaux3
1Department of Environmental Toxicology, Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, Switzerland.
Ultrafine particles like benzo[a]pyrene (BaP) pose skin health risks. Stable isotope labeling and LC-HRMS reveal five key BaP metabolites in human skin models, advancing pollution impact research.
Area of Science:
- Environmental Health
- Toxicology
- Analytical Chemistry
Background:
- Ultrafine particles (UFPs) containing polycyclic aromatic hydrocarbons (PAHs), such as benzo[a]pyrene (BaP), are environmental pollutants linked to health concerns.
- The skin is a primary target for environmental contaminants, necessitating research into pollutant metabolism.
- Existing in vitro models often lack metabolic activity, and animal testing faces ethical limitations.
Purpose of the Study:
- To investigate the metabolic fate of benzo[a]pyrene (BaP) in a human skin model.
- To develop and validate a novel analytical approach for characterizing BaP metabolism.
- To identify BaP metabolites formed in the skin.
Main Methods:
- Utilized a 3D reconstructed human epidermis (RHE) model for physiological relevance.
- Employed stable isotope labeling (SIL) with deuterium-labeled BaP (BaP-d12) for precise quantification.
- Applied liquid chromatography-high-resolution mass spectrometry (LC-HRMS) coupled with stable isotope filtering for metabolite identification.
Main Results:
- Identified five distinct BaP phase I metabolites within the RHE model.
- Detected mono-hydroxylated, dihydroxylated, and quinone derivatives of BaP.
- Demonstrated the efficacy of SIL-LC-HRMS for comprehensive metabolic profiling.
Conclusions:
- Coupling stable isotope labeling with LC-HRMS provides a powerful tool for characterizing BaP metabolic pathways in human skin.
- The identified metabolites enhance understanding of BaP detoxification and potential adverse effects.
- This analytical strategy is promising for studying the metabolism of other environmental pollutants in skin.
More Related Videos
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Drug Metabolism: Phase I Reactions

